FR2270853A1 - - Google Patents

Info

Publication number
FR2270853A1
FR2270853A1 FR7515190A FR7515190A FR2270853A1 FR 2270853 A1 FR2270853 A1 FR 2270853A1 FR 7515190 A FR7515190 A FR 7515190A FR 7515190 A FR7515190 A FR 7515190A FR 2270853 A1 FR2270853 A1 FR 2270853A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7515190A
Other languages
French (fr)
Other versions
FR2270853B1 (cg-RX-API-DMAC10.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Maggioni and C SpA
Original Assignee
Maggioni and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maggioni and C SpA filed Critical Maggioni and C SpA
Publication of FR2270853A1 publication Critical patent/FR2270853A1/fr
Application granted granted Critical
Publication of FR2270853B1 publication Critical patent/FR2270853B1/fr
Expired legal-status Critical Current

Links

FR7515190A 1974-05-15 1975-05-15 Expired FR2270853B1 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2270974 1974-05-15

Publications (2)

Publication Number Publication Date
FR2270853A1 true FR2270853A1 (cg-RX-API-DMAC10.html) 1975-12-12
FR2270853B1 FR2270853B1 (cg-RX-API-DMAC10.html) 1978-09-08

Family

ID=11199496

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7515190A Expired FR2270853B1 (cg-RX-API-DMAC10.html) 1974-05-15 1975-05-15

Country Status (4)

Country Link
JP (1) JPS5123248A (cg-RX-API-DMAC10.html)
DE (1) DE2521113A1 (cg-RX-API-DMAC10.html)
FR (1) FR2270853B1 (cg-RX-API-DMAC10.html)
GB (1) GB1461240A (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
CA2688161C (en) 2007-06-04 2020-10-20 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HK1220611A1 (zh) 2013-03-15 2017-05-12 Bausch Health Ireland Limited 用於治疗胃肠道病症的组成物
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
CN113388007A (zh) 2013-06-05 2021-09-14 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
FI3911648T3 (fi) 2019-01-18 2025-01-10 Astrazeneca Ab 6'-[[[(1s,3s)-3-[[5-(difluorometoksi)-2-pyrimidinyyli]amino]syklopentyyli]amino][1(2h),3'-bipyridin]-2-oni pcsk9:n estäjänä ja menetelmät sen käyttöön

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2482956A1 (fr) * 1980-05-22 1981-11-27 Synthelabo Cyclohexylalkylamines, leurs procedes de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
DE2521113A1 (de) 1976-03-18
JPS5123248A (en) 1976-02-24
FR2270853B1 (cg-RX-API-DMAC10.html) 1978-09-08
GB1461240A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
FI750828A7 (cg-RX-API-DMAC10.html)
FI753202A7 (cg-RX-API-DMAC10.html)
DK433174A (cg-RX-API-DMAC10.html)
FR2270853B1 (cg-RX-API-DMAC10.html)
FR2276032B1 (cg-RX-API-DMAC10.html)
FI50558B (cg-RX-API-DMAC10.html)
FI753109A7 (cg-RX-API-DMAC10.html)
CS169624B1 (cg-RX-API-DMAC10.html)
CS177965B1 (cg-RX-API-DMAC10.html)
CS172774B1 (cg-RX-API-DMAC10.html)
CS163684B1 (cg-RX-API-DMAC10.html)
CS166090B1 (cg-RX-API-DMAC10.html)
DE2420130A1 (cg-RX-API-DMAC10.html)
CS171014B1 (cg-RX-API-DMAC10.html)
CS169423B1 (cg-RX-API-DMAC10.html)
FI191374A7 (cg-RX-API-DMAC10.html)
FI373374A7 (cg-RX-API-DMAC10.html)
CS172114B1 (cg-RX-API-DMAC10.html)
CS172732B1 (cg-RX-API-DMAC10.html)
CS175815B1 (cg-RX-API-DMAC10.html)
CH607919A5 (cg-RX-API-DMAC10.html)
CH604692A5 (cg-RX-API-DMAC10.html)
CH589893A5 (cg-RX-API-DMAC10.html)
CH593683A5 (cg-RX-API-DMAC10.html)
CH594117A5 (cg-RX-API-DMAC10.html)

Legal Events

Date Code Title Description
ST Notification of lapse